Department of Integrative Physiology, Shiga University of Medical Science, Otsu, 520-2192, Japan.
Division of Neurobiology and Bioinformatics, National Institute for Physiological Sciences, Okazaki, 444-8787, Japan.
Neurochem Res. 2018 Jan;43(1):219-226. doi: 10.1007/s11064-017-2422-6. Epub 2017 Oct 28.
Minocycline not only has antibacterial action but also produces a variety of pharmacological effects. It has drawn considerable attention as a therapeutic agent for symptoms caused by inflammation in many neurological disorders, leading to several clinical trials. Although some of these effects are mediated through its function of suppressing microglial activation, it is not clear whether minocycline acts on other cell types in the adult brain. In this study, we utilized a colony-forming neurosphere assay, in which neural stem cells (NSCs) clonally proliferate to form floating colonies, called neurospheres. We found that minocycline (at therapeutically relevant concentrations in cerebrospinal fluid) enhances the self-renewal capability of NSCs derived from the subependymal zone of adult mouse brain and facilitates their differentiation into oligodendrocytes. Importantly, these effects were independent of a suppression of microglial activation and were specifically observed with minocycline (among tetracycline derivatives). In addition, the size of the NSC population in the adult brain was increased when minocycline was infused into the lateral ventricle by an osmotic minipump in vivo. While precise molecular mechanisms of how minocycline alters the behavior of adult NSCs remain unknown, our data provide a basis for the clinical use of minocycline to treat neurodegenerative and demyelinating diseases.
米诺环素不仅具有抗菌作用,还能产生多种药理作用。它作为一种治疗许多神经紊乱引起的炎症症状的药物引起了相当多的关注,从而引发了几项临床试验。尽管这些作用中的一些是通过抑制小胶质细胞的激活来介导的,但米诺环素是否对成年大脑中的其他细胞类型起作用尚不清楚。在这项研究中,我们利用集落形成神经球测定法,其中神经干细胞(NSC)克隆性增殖形成悬浮集落,称为神经球。我们发现米诺环素(在脑脊液中具有治疗相关浓度)增强了源自成年小鼠脑室下区的 NSCs 的自我更新能力,并促进其分化为少突胶质细胞。重要的是,这些作用与抑制小胶质细胞的激活无关,并且仅在用米诺环素(四环素有特定的衍生物)观察到。此外,当通过体内渗透微型泵将米诺环素注入侧脑室时,成年大脑中的 NSC 群体的大小增加。虽然米诺环素如何改变成年 NSC 行为的确切分子机制尚不清楚,但我们的数据为米诺环素治疗神经退行性和脱髓鞘疾病的临床应用提供了依据。